GlassScriptPhysician profile
Kevin K Palmer
NPI 1396962627
$84,313.62
in general payments reported to CMS, 2019-2025
35 companies · $10K in 2025
The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $12K · 2021: $8,479 · 2022: $13K · 2023: $13K · 2024: $15K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $26K · Food and Beverage: $6,771 · Consulting Fee: $3,500 · Travel and Lodging: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,015.65 |
| Food and Beverage | $6,771.22 |
| Consulting Fee | $3,500.00 |
| Travel and Lodging | $1,472.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $49,294.99 | 2019-2025 | Fibula Nail |
| US Implant Solutions, LLC | $21,562.50 | 2019-2021 | |
| Ossio INC | $8,208.36 | 2022-2024 | |
| Zyla Life Sciences, INC. | $1,065.37 | 2019-2020 | |
| Smith+Nephew, INC. | $819.80 | 2019-2024 | Grafix Pl, Stravix Pl, Oasis Micro |
| Wright Medical Technology, INC. | $314.04 | 2019 | |
| Stryker Corporation | $271.60 | 2019-2024 | Infinity Adaptis, Allomatrix |
| Djo, LLC | $240.66 | 2019-2023 | Cmf |
| Nalu Medical, INC. | $224.73 | 2023 | Nalu Neurostimulation System |
| Treace Medical Concepts, INC. | $224.39 | 2023-2025 | |
| Carbofix Orthopedics INC | $211.83 | 2020-2025 | |
| Fusion Orthopedics USA, LLC | $204.92 | 2024-2025 | |
| Crossroads Extremity Systems, LLC | $199.86 | 2019-2020 | |
| Southern Edge Orthopaedics, INC. | $185.26 | 2024-2025 | |
| Acera Surgical, INC. | $150.72 | 2025 | Restrata Wound Matrix |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $119.82 | 2022-2024 | Apligraf |
| Zimmer Biomet Holdings, INC. | $116.26 | 2020-2021 | |
| Lifenet Health | $105.75 | 2024 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $96.96 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $93.27 | 2019 | |
| Solventum Corporation | $84.99 | 2024 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice |
| Bioventus LLC | $61.96 | 2020-2022 | |
| Horizon Therapeutics Plc | $61.17 | 2021-2023 | Krystexxa |
| Kci USA, INC. | $58.14 | 2020-2022 | |
| Amgen INC. | $54.85 | 2024 | Krystexxa |
| Embody, INC. | $48.50 | 2022 | |
| Depuy Synthes Sales INC. | $42.11 | 2022 | |
| Osiris Therapeutics INC. | $41.16 | 2019 | |
| Orthofix Medical, INC. | $39.76 | 2019-2024 | Physio-Stim |
| Kerecis Limited | $30.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Assertio Therapeutics, INC. | $20.66 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.42 | 2019 | |
| Orthogenrx INC. | $16.27 | 2019 | |
| Ermi LLC | $14.75 | 2019 | |
| Merck Sharp & Dohme LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.